BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34957655)

  • 1. HPV16 E6 promotes cell proliferation, migration, and invasion of human cervical cancer cells by elevating both EMT and stemness characteristics.
    Lu Y; Chen Y; Zhang Z; Li M; Chen X; Tu K; Li L
    Cell Biol Int; 2022 Apr; 46(4):599-610. PubMed ID: 34957655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
    Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A1E reduces stemness and self-renewal in HPV 16-positive cervical cancer stem cells.
    Kwon T; Bak Y; Ham SY; Yu DY; Yoon DY
    BMC Complement Altern Med; 2016 Feb; 16():42. PubMed ID: 26832364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression
    Shu S; Li Z; Liu L; Ying X; Zhang Y; Wang T; Zhou X; Jiang P; Lv W
    Front Oncol; 2022; 12():900856. PubMed ID: 35875100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
    Hao S; Meng Q; Sun H; Yang X; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
    Mol Carcinog; 2024 Feb; 63(2):339-355. PubMed ID: 37988232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 E6 regulates the proliferation, invasion, and apoptosis of cervical cancer cells by downregulating miR-504.
    Zhang L; Lai Y; Sun Y; Xu B; Qiang X; Zhou X; Wang T
    Transl Cancer Res; 2020 Dec; 9(12):7588-7595. PubMed ID: 35117358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells.
    Cheng YX; Chen GT; Yang X; Wang YQ; Hong L
    Curr Med Sci; 2018 Apr; 38(2):212-221. PubMed ID: 30074178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
    Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
    Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Zhang J; Yu X; Guo Y; Wang D
    Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
    Zhu D; Ye M; Zhang W
    Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin decreases epithelial‑mesenchymal transition by a Pirin‑dependent mechanism in cervical cancer cells.
    Aedo-Aguilera V; Carrillo-Beltrán D; Calaf GM; Muñoz JP; Guerrero N; Osorio JC; Tapia JC; León O; Contreras HR; Aguayo F
    Oncol Rep; 2019 Nov; 42(5):2139-2148. PubMed ID: 31436299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
    Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
    Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation.
    Meng Q; Zhang Y; Sun H; Yang X; Hao S; Liu B; Zhou H; Wang Y; Xu ZX
    Redox Biol; 2024 May; 71():103108. PubMed ID: 38457903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.
    Rho SB; Lee SH; Byun HJ; Kim BR; Lee CH
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
    Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.